239 related articles for article (PubMed ID: 21051007)
1. Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.
Nading MA; Balch CM; Sober AJ
Semin Cutan Med Surg; 2010 Sep; 29(3):142-7. PubMed ID: 21051007
[TBL] [Abstract][Full Text] [Related]
2. New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
Semin Surg Oncol; 2003; 21(1):43-52. PubMed ID: 12923915
[TBL] [Abstract][Full Text] [Related]
3. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
[TBL] [Abstract][Full Text] [Related]
4. Current melanoma staging.
Petro A; Schwartz J; Johnson T
Clin Dermatol; 2004; 22(3):223-7. PubMed ID: 15262308
[TBL] [Abstract][Full Text] [Related]
5. Classification and staging of melanoma.
Gershenwald JE; Buzaid AC; Ross MI
Clin Lab Med; 2000 Dec; 20(4):785-815. PubMed ID: 11221515
[TBL] [Abstract][Full Text] [Related]
6. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D
Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596
[TBL] [Abstract][Full Text] [Related]
7. Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma.
Retsas S; Mastrangelo MJ
Semin Oncol; 2007 Dec; 34(6):491-7. PubMed ID: 18083372
[TBL] [Abstract][Full Text] [Related]
8. [The new TNM classification of malignant melanoma].
Oláh J; Dobozy A
Magy Onkol; 2003; 47(1):59-61. PubMed ID: 12704456
[TBL] [Abstract][Full Text] [Related]
9. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
10. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
Busam KJ
Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
[TBL] [Abstract][Full Text] [Related]
11. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
12. AJCC melanoma staging update: impact on dermatopathology practice and patient management.
Piris A; Mihm MC; Duncan LM
J Cutan Pathol; 2011 May; 38(5):394-400. PubMed ID: 21385199
[TBL] [Abstract][Full Text] [Related]
13. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
Gimotty PA; Guerry D; Ming ME; Elenitsas R; Xu X; Czerniecki B; Spitz F; Schuchter L; Elder D
J Clin Oncol; 2004 Sep; 22(18):3668-76. PubMed ID: 15302909
[TBL] [Abstract][Full Text] [Related]
14. [Primary cutaneous melanoma: prognostic factors not included in the classification of the American Joint Committee on Cancer].
Tejera-Vaquerizo A; Solís-García E; Ríos-Martín JJ; Moreno-Ramírez D
Actas Dermosifiliogr; 2011 May; 102(4):255-63. PubMed ID: 21440241
[TBL] [Abstract][Full Text] [Related]
15. Progress but not enough: the 2009 (7th) revision of the American Joint Committee on Cancer (AJCC) for melanoma staging and classification.
Retsas S
J BUON; 2011; 16(1):38-9. PubMed ID: 21674847
[TBL] [Abstract][Full Text] [Related]
16. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
17. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
18. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
19. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.
Caldarella A; Fancelli L; Manneschi G; Chiarugi A; Nardini P; Crocetti E
J Cancer Res Clin Oncol; 2016 Jan; 142(1):73-6. PubMed ID: 26113451
[TBL] [Abstract][Full Text] [Related]
20. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
Ross MI
Surg Oncol Clin N Am; 2006 Apr; 15(2):341-52. PubMed ID: 16632219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
